Page last updated: 2024-11-03

probenecid and Autoimmune Diabetes

probenecid has been researched along with Autoimmune Diabetes in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engler, CB1
Sander, B1
Larsen, M1
Koefoed, P1
Parving, HH1
Lund-Andersen, H1
Magoula, I1
Tsapas, G1
Paletas, K1
Mavromatidis, K1

Trials

1 trial available for probenecid and Autoimmune Diabetes

ArticleYear
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Acta ophthalmologica, 1994, Volume: 72, Issue:6

    Topics: Adult; Biological Transport, Active; Blood; Blood-Retinal Barrier; Capillary Permeability; Cross-Ove

1994

Other Studies

1 other study available for probenecid and Autoimmune Diabetes

ArticleYear
Insulin-dependent diabetes and renal hypouricemia.
    Nephron, 1991, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Creatinine; Diabetes Mellitus, Type 1; Female; Humans; Kidney Tubules; Male; Prob

1991